Identification of blood-based biomarkers for diagnosis and prognosis of Parkinson's disease: A systematic review of proteomics studies
SS Chelliah, S Bhuvanendran, KB Magalingam… - Ageing Research …, 2022 - Elsevier
Abstract Parkinson's Disease (PD), a neurodegenerative disorder, is characterised by the
loss of motor function and dopamine neurons. Therapeutic avenues remain a challenge due …
loss of motor function and dopamine neurons. Therapeutic avenues remain a challenge due …
Association between genetic polymorphisms and other attributing factors with lipid profiles among statin users: a cross-sectional retrospective study
Background Statins are well known for their efficacy to improve lipid profiles. Their efficacy
varies between individuals and can be modified by patient factors such as genetic …
varies between individuals and can be modified by patient factors such as genetic …
Association of apolipoprotein E (ApoE) polymorphisms with risk of primary hyperuricemia in Uygur men, Xinjiang, China
YP Sun, B Zhang, L Miao, XM Wang, JH Yu… - Lipids in health and …, 2015 - Springer
Abstract Background Apolipoprotein E (ApoE) participates in lipoprotein metabolism and
immune regulation. This study assessed association between ApoE polymorphisms with …
immune regulation. This study assessed association between ApoE polymorphisms with …
[HTML][HTML] Association study between DNA methylation and genetic variation of APOE gene with the risk of coronary artery disease
H Ghaznavi, AA Kiani… - Molecular Biology …, 2018 - ncbi.nlm.nih.gov
Coronary artery disease (CAD) is a common health problem with a high rate of disability and
death. Dyslipidemia and altered metabolism of Apo-lipoproteins are involved in the CAD …
death. Dyslipidemia and altered metabolism of Apo-lipoproteins are involved in the CAD …
[HTML][HTML] Endothelial nitric oxide synthase Glu 298 Asp (G894T) and Apolipoprotein E gene polymorphism as possible risk factors for coronary heart disease among …
S Arafa, S Abdelsalam, AH El-Gilany… - The Egyptian Heart …, 2018 - Elsevier
Abstract In Egypt, The prevalence of chronic heart disease (CHD) is 8.3%. It is the principal
cause of death and is responsible for 22% of total mortality. The age-adjusted mortality rate …
cause of death and is responsible for 22% of total mortality. The age-adjusted mortality rate …
APOLIPOPROTEIN E (APOE) GENE POLYMORPHISMS AND THEIR ASSOCIATION WITH CARDIOVASCULAR DISEASE (CVD) IN TYPE 2 DIABETES MELLITUS …
NAS Muzaidi, MM Sopian - Journal of Health and Translational …, 2024 - ojie.um.edu.my
Apolipoprotein E (ApoE) is well known for its crucial role in lipid metabolism and is
associated with an increased risk of cardiovascular disease (CVD) among subjects with type …
associated with an increased risk of cardiovascular disease (CVD) among subjects with type …
Complex assessment of efficacy of statins prescribed at most by clinicians
AS Sivkov, EV Shih, MA Osadchuk… - Cardiovascular …, 2018 - cardiovascular.elpub.ru
Aim. To evaluate a complex clinical efficacy, tolerability and safety of statin drugs—
simvastatin, atorvastatin, rosuvastatin in patients with hyperlipidemia (HL). Material and …
simvastatin, atorvastatin, rosuvastatin in patients with hyperlipidemia (HL). Material and …
Correlation of ApoE Gene Polymorphism with Coronary Heart Disease Severity in Patients with Acute Coronary Syndrome Who Receive Statin Therapy, Padang …
Abstract Coronary Heart Disease (CHD) is still the most common cause of death. Ischemic
heart disease causes more than 7 million (12.8%) deaths worldwide. It is estimated that …
heart disease causes more than 7 million (12.8%) deaths worldwide. It is estimated that …
The Effects of PCSK9 and Apolipoprotein E Functional Gene Variations On Hypercholesterolemia and Clinical Phenotype in Restenosis Patients After Percutaneous …
Background: In-stent-restenosis is a case restricting the benefits of percutaneous-
transluminal coronary angioplasty (PTCA). PCSK9 controls LDLR levels, and variations in …
transluminal coronary angioplasty (PTCA). PCSK9 controls LDLR levels, and variations in …
Association of lipoprotein lipase gene polymorphisms with lipid profiles in atherosclerotic coronary artery disease
I Elmadbouh, M El-Shafiey, A Al-Hamid… - Menoufia Medical …, 2014 - go.gale.com
Background Coronary artery disease (CAD) is a complex disease with well-documented
genetic and environmental components. Lipoprotein lipase (LPL) is considered a potential …
genetic and environmental components. Lipoprotein lipase (LPL) is considered a potential …